Grund Nicholas, Chief Officer of Akebia Therapeutics AKBA, has filed 0 purchases and 3 sales on the open market. Over the past 12 months that comes to a net sale of $117.9K. The latest trade was on 02/02.

GN

GN

Grund Nicholas

Chief Commercial Officer

Company

Akebia Therapeutics AKBA

First filing

24/02/02

Trades

9 trades

Buys / sales

0 / 3

12-month net buying

−$117.9K

Last trade

02/02

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Akebia TherapeuticsAKBA	Open-market sale10b5-1 plan	02/02	02/04	84,829 sh2 trades	$1.39avg.	$117,912.31	−13.1%
Akebia TherapeuticsAKBA	Open-market sale10b5-1 plan	25/02/03	25/02/04	55,621 sh	$2.10	$116,804.1	−11.2%